Mario Alberto Accardi
CIK 2074392 · Chief Executive Officer · last filed 2026-06-24
Mario Alberto Accardi is a Chief Executive Officer who has filed 20 SEC Form 4 insider transactions across 1 company since 2025. The most recent filing, for CNTA, was dated Jun 24, 2026. Across all open-market trades the lifetime net is −$1.4M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
20
-$1.44M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc (CNTA) Delisted | Chief Executive Officer | 0 | $40.50 | $0 | -$1.44M | 12 | 2026-06-24 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-24 | Centessa Pharmaceuticals plc (CNTA) Delisted | Disp (D) | −243,282 | $0 | EDGAR |
| 2026-05-18 | Centessa Pharmaceuticals plc (CNTA) Delisted | Tax (F) | −604 | -$23.8K | EDGAR |
| 2026-02-03 | Centessa Pharmaceuticals plc (CNTA) Delisted | Mixed | +65,085 | -$71.6K | EDGAR |
| 2025-12-09 | — | Notice (144) | −10,000 | -$293.0K | EDGAR |
| 2025-12-09 | Centessa Pharmaceuticals plc (CNTA) Delisted | Sell (S) | −10,000 | -$288.3K | EDGAR |
| 2025-12-08 | — | Notice (144) | −10,000 | -$300.0K | EDGAR |
| 2025-12-08 | Centessa Pharmaceuticals plc (CNTA) Delisted | Mixed | −5,000 | -$252.3K | EDGAR |
| 2025-11-03 | Centessa Pharmaceuticals plc (CNTA) Delisted | Tax (F) | −593 | -$14.8K | EDGAR |
| 2025-10-27 | — | Notice (144/A) | −8,000 | -$200.0K | EDGAR |
| 2025-10-27 | — | Notice (144) | −8,000 | -$200.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.